ASX Announcement – 20 October 202 6 MRI LIVER FIBROSIS DEVICE EPoC CLINICAL TRIAL PRELIMINARY RESULTS WEBINAR Resonance Health Ltd (Resonance or Company) (ASX: RHT) expects to release the preliminary results of its Non-invasive MRI Liver Fibrosis Medical Device extended-proof-of concept (EPoC)...
Liver Fibrosis Device - Clinical Trial Results - Webinar
Filed with ASX · · 2 pages · English
Release
Story so far
Earlier from Resonance Health
- AGM Date & Director Nomination Closing Date
- Change in Substantial Holding
- Global Strategic Alliance & MSA with Image Analysis Group
- Appendix 4G & Corporate Governance Statement
- FY26 Full Year Results & Investor Webinar
Later from Resonance Health
- Notice of Annual General Meeting/Proxy Form
- Trading Halt
- Liver Fibrosis Device - EPoC Study Results
- $6.0 Million Placement Oversubscribed
- Proposed issue of securities - RHT
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health